Skip to content
Discreet worldwide shipping LegitScript Certified Cold-chain delivery 30-day returns
Upload Rx
0 0
Lenvima 4 mg Capsule 50% Off
Sourced directly from Eisai

Lenvima 4 mg Capsule

Capsule · 20 Capsules per Box

$430.00 $860.00 incl. taxes
Composition
—
Manufacturer
Eisai
Pack
20 Capsules per Box
No reviews yet Write a review
  • Genuine stock
  • Discreet packaging
  • Export documents on request
In stock

Standard 7–15 business days · Express 4–6 business days. Enter your postal code to confirm.

About Lenvima 4 mg Capsule

Lenvima 4 mg Capsule contains lenvatinib, a targeted anti-cancer medicine used for thyroid cancer, liver cancer, kidney cancer, and endometrial cancer. It works by blocking tumor growth pathways and reducing blood supply to cancer cells. Used under specialist oncology supervision.


What Is Lenvima 4 mg Capsule?

Lenvima is the brand name for lenvatinib, an oral targeted therapy that belongs to a class of medicines known as multi-kinase inhibitors.

Cancer cells do not grow on their own.

They depend on signals that tell them when to divide and blood vessels that supply oxygen and nutrients. Lenvatinib disrupts both processes simultaneously.

That is why oncologists often use Lenvima when the goal is not simply to attack cancer cells directly, but to interfere with the biological systems tumors rely on to survive.

Today, Lenvima is approved in multiple countries for several difficult-to-treat cancers and has become an important treatment option in modern oncology.


How It Works — And Why It Is Different From Traditional Chemotherapy

Chemotherapy generally attacks rapidly dividing cells.

Lenvatinib takes a different approach.

It targets specific proteins involved in tumor growth and blood vessel formation, including VEGF receptors, FGF receptors, PDGF receptors, RET, and KIT signaling pathways.

By blocking these pathways, Lenvima may:

  • Slow tumor growth
  • Reduce blood supply to tumors
  • Delay disease progression
  • Improve progression-free survival in eligible patients
  • Enhance outcomes when combined with other cancer therapies

This targeted approach is one reason Lenvima has become a standard treatment option in several advanced cancers.


Which Cancers Is Lenvima Used For?

Lenvatinib is commonly prescribed for:

  • Radioactive iodine-refractory differentiated thyroid cancer
  • Unresectable hepatocellular carcinoma (liver cancer)
  • Advanced renal cell carcinoma (kidney cancer)
  • Advanced endometrial carcinoma
  • Selected oncology protocols determined by specialists

Treatment decisions depend on cancer type, disease stage, previous therapies, and overall patient health.


Medical Uses & Indications

Condition Clinical Use
Differentiated Thyroid Cancer Disease progression control
Hepatocellular Carcinoma (HCC) Advanced liver cancer treatment
Renal Cell Carcinoma (RCC) Kidney cancer therapy
Endometrial Cancer Advanced or recurrent disease treatment
Advanced Solid Tumors Specialist-directed use

Why Oncologists Use Lenvima In Advanced Cancer Care

Cancer treatment is increasingly moving away from one-size-fits-all chemotherapy.

Targeted therapies such as lenvatinib allow specialists to attack specific biological pathways that drive tumor growth.

For patients with advanced thyroid cancer, liver cancer, or kidney cancer, slowing disease progression can be just as important as shrinking tumors.

That is where Lenvima has demonstrated its value.

Its role is not to cure every cancer. Its role is to help control cancers that rely on angiogenesis and growth signaling pathways to spread.


Typical Dosage Guide

Strength Common Use
4 mg Dose adjustment and individualized regimens
10 mg Standard oncology dosing component
Combination Dosing Multiple capsules used to achieve prescribed daily dose

The total daily dose varies significantly depending on cancer type, body weight, treatment protocol, liver function, and physician recommendations.


Product Information

Attribute Details
Generic Name Lenvatinib
Brand Name Lenvima®
Strength 4 mg
Dosage Form Capsule
Drug Class Multi-Kinase Inhibitor
Route Oral
Used For Thyroid Cancer, Liver Cancer, Kidney Cancer, Endometrial Cancer

People Also Ask

Is Lenvima chemotherapy?

No. Lenvima is a targeted therapy, not traditional chemotherapy. It works by blocking specific proteins involved in tumor growth and blood vessel formation.

What cancers does Lenvima treat?

Lenvima is commonly used for thyroid cancer, liver cancer, kidney cancer, and endometrial cancer under specialist supervision.

How long do patients take Lenvima?

Treatment duration varies depending on response, side effects, disease progression, and oncology protocols.

Can Lenvima shrink tumors?

In some patients, lenvatinib may reduce tumor size or slow tumor progression. Individual responses vary.

Is Lenvima used with immunotherapy?

Yes. In certain cancers, lenvatinib may be combined with immunotherapy agents such as pembrolizumab under specialist guidance.

Is Lenvima a cure for cancer?

No. Lenvima is designed to help control cancer progression and improve treatment outcomes, but it is not considered a universal cure.


Frequently Asked Questions

1. Do you ship Lenvima 4 mg Capsules internationally?

Answer: Yes. International shipping is available to many countries, subject to local import regulations and product availability.

2. Is this original Lenvima by Eisai?

Answer: Depending on stock availability, original branded Lenvima® manufactured by Eisai may be supplied.

3. How is the product packaged?

Answer: Products are supplied in manufacturer-sealed pharmaceutical packaging and packed securely for international delivery.

4. How can I verify authenticity?

Answer: Verify manufacturer information, batch number, expiry date, and original packaging upon receipt.


Product Information Table

Attribute Details
Generic Name Lenvatinib
Brand Name Lenvima®
Strength 4 mg
Dosage Form Capsule
Administration Oral
Drug Category Targeted Cancer Therapy
Therapeutic Area Oncology

Also in Cancer Care

View all
View all